Skip to main content
Erschienen in: Reactions Weekly 1/2021

01.01.2021 | Case report

Busulfan/cyclophosphamide/melphalan

Graft failure: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Porta F, et al. Effect of new drugs in the treatment of bone marrow transplantion: Severe complications in a child affected by myelodiplastic syndrome. Bone Marrow Transplantation 53: 411-412 abstr. P353, 2019. Available from: URL: http://doi.org/10.1038/s41409-018-0354-7 [abstract] Porta F, et al. Effect of new drugs in the treatment of bone marrow transplantion: Severe complications in a child affected by myelodiplastic syndrome. Bone Marrow Transplantation 53: 411-412 abstr. P353, 2019. Available from: URL: http://​doi.​org/​10.​1038/​s41409-018-0354-7 [abstract]
Metadaten
Titel
Busulfan/cyclophosphamide/melphalan
Graft failure: case report
Publikationsdatum
01.01.2021
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-88017-4

Weitere Artikel der Ausgabe 1/2021

Reactions Weekly 1/2021 Zur Ausgabe

Case report

Thiamazole

Case report

Apixaban/aspirin

Case report

Rifampicin

Case report

Immune-globulin